Pure Global

ASCA IgA - India CDSCO Medical Device Registration

ASCA IgA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000558_f746baefdc9e85a4f3ba7258d4db73b5_85a6ee7d61e41a4865c6ddca054d9f79. This device is marketed under the brand name Anti-Gliadin IgG. The license holder is Sebia Diagnostics India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
ASCA IgA
UID: IMP/IVD/2021/000558_f746baefdc9e85a4f3ba7258d4db73b5_85a6ee7d61e41a4865c6ddca054d9f79

Brand Name

Anti-Gliadin IgG

Device Class

Class B

Approving Authority

CDSCO

Product Information

ASCA IgA is an ELISA-based test system for the quantitative measurement of IgA class anti-Saccharomyces cerevisiae autoantibodies (Anti-Gliadin IgG) in human serum or plasma samples. This product is intended for professional in vitro diagnostic use only. Accurate diagnosis of inflammatory bowel disease (Anti-Gliadin IgG), in particular the differentiation between the ulcerative colitis and Crohnโ€™s disease, is important for treatment and prognosis. ASCA are strongly associated to Crohnโ€™s disease. IgG as well as IgA ASCA show a high specificity for Crohnโ€™s disease, and support the differential dignosis of IBD, when combined with other serological markers and clinical tests

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing